Phibro Animal Health (NASDAQ: PAHC) — Perfil da empresa, notícias e dados financeiros
Phibro Animal Health develops animal health and nutrition products, including vaccines and feed additives for livestock.
Phibro Animal Health
Phibro Animal Health (NASDAQ:PAHC) is engaged in the development, manufacture, and marketing of a wide range of animal health and nutrition products. The company's portfolio includes medicated feed additives, nutritional specialty products, and vaccines that cater to livestock, including poultry, swine, beef, and dairy cattle, as well as aquaculture. Strategically committed to enhancing animal health and productivity, Phibro aims to contribute to a more sustainable and efficient global food supply. Through ongoing research and development efforts, the company focuses on innovation to address the evolving needs of animal health and nutrition, striving for excellence in its projects and operations to deliver value to customers and shareholders alike.
Resumo
Operações
Produtos e/ou serviços de Phibro Animal Health
- Medicated feed additives (MFAs) for improving animal health and growth efficiency.
- Vaccines to prevent and control infectious diseases in livestock and poultry.
- Feed ingredients that enhance nutrition and digestive efficiency in animals.
- Animal health and nutritional products for aquaculture, promoting growth and disease resistance in fish and shrimp.
- Performance products including enzymes and antimicrobials that optimize feed utilization.
- Mineral nutrition products to support the overall health and productivity of livestock.
equipe executiva do Phibro Animal Health
- Jack Clifford BendheimExecutive Chairman
- Daniel M. BendheimCEO, President & Director
- Glenn C. DavidChief Financial Officer
- Larry L. MillerChief Operating Officer
- Judith A. WeinsteinSenior VP, General Counsel & Corporate Secretary
- Jonathan BendheimExecutive VP of Talent, Technology and Business Development & Director
- Lisa Ann EscuderoSenior Vice President of Human Resources
- Ramon FuenmayorPresident South America Region
- Samson LiPresident of Asia Pacific Region
- Todd ArmstrongPresident of North American Region
Histórico de dividendos
Dividendos por ação pagos pela Phibro Animal Health , por ano fiscal.
| Ano fiscal | Intermediário | Final | Especial | Total |
|---|---|---|---|---|
| FY2027(até o momento) | — | — | — | $0.1200 |
| FY2026 | — | — | — | $0.4800 |
| FY2025 | — | — | — | $0.4800 |
| FY2024 | — | — | — | $0.4800 |
| FY2023 | — | — | — | $0.4800 |
Principais indicadores financeiros
Resultados divulgados pela Phibro Animal Health , em USD.
- Cap. de mercado
- 1,5 bi
- Receita (TTM)
- 1,5 bi
- P/L
- 15.8
- LPA (diluído, TTM)
- 2.4
- Dividend yield
- 1.3%
- Margem de lucro
- 6.6%
| Fim do ano fiscal | Receita | Resultado operacional | Lucro líquido |
|---|---|---|---|
| 1,5 bi | 198,4 mi | 99,7 mi | |
| 1,3 bi | 110,5 mi | 48,3 mi | |
| 1 bi | 53,3 mi | 2,4 mi | |
| 977,9 mi | 71,8 mi | 32,6 mi |